Rosuvastatin safety and efficacy in coronary heart disease patients

Rosuvastatin safety and efficacy in coronary heart disease patients

Aim. To study rosuvastatin safety and effects on lipid profile (LP) in coronary heart disease (CHD) patients. Material and methods. The study included 30 males (mean age 57±9 years) with diagnosed CHD, Functional Class II-III stable effort angina, receiving adequate basic therapy. In all participant...

Full description

Bibliographic Details
Main Authors:	I. V. Sergienko, M. V. Ezhov, V. P. Masenko
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2006-10-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	hyperlipidemia statins rosuvastatin coronary heart disease
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1292

Similar Items

High-intensity therapy: rationale, indications and safety issues. Prospects of rosuvastatin in clinical practice
by: M. G Bubnova
Published: (2017-12-01)

Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome
by: Sh. A. Mostafa, et al.
Published: (2018-11-01)

Postprandial hyperlipidemia as a coronary atherosclerosis factor in patients with metabolic syndrome; corrective potential of rosuvastatin therapy
by: T. V. Krovyakova, et al.
Published: (1970-01-01)

ESCADRA: a randomised study. Part I: lipid-lowering effectiveness, safety and tolerability of ezetimibe, initial doses of original statins, and the combination of ezetimibe with initial doses of statins in patients with coronary heart disease and hyperlipidemia
by: M. Yu. Zubareva, et al.
Published: (2010-12-01)

Efficacy and safety of the intensive dose of rosuvastatin 40 mg/day in patients with acute coronary syndrome and at high risk of cardiovascular disease-ROSUVEES-2
by: Chetan P. Shah, et al.
Published: (2016-11-01)

A comparative study of atorvastatin and rosuvastatin on lipid lowering efficacy in hyperlipidemic patients
by: Samia Haque Tonu, et al.
Published: (2018-03-01)

Features of using of a fixed combination of rosuvastatin and ezetimibe for effective hypolipidemic therapy
by: I. A. Alekseeva, et al.
Published: (2020-10-01)

LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS
by: A. N. Meshkov
Published: (2015-12-01)

Effect and Safety of Rosuvastatin in Acute Ischemic Stroke
by: Ji Hoe Heo, et al.
Published: (2016-01-01)

Comparative efficacy between atorvastatin and rosuvastatin in the prevention of cardiovascular disease recurrence
by: Sofía Perez-Calahorra, et al.
Published: (2019-12-01)

Randomised study of ezetimibe, start doses of original statins, and their combination in patients with coronary heart disease and hyperlipidemia Part 2. Therapy effects on the levels of C-reactive protein and proinflammatory cytokines
by: A. V. Susekov, et al.
Published: (2011-12-01)

Modern views on clinical and economical effectiveness of rosuvastatin
by: S. K. Zyryanov, et al.
Published: (2008-02-01)

Effect of statins on hearing function and subjective tinnitus in hyperlipidemic patients
by: Yücel Hilal, et al.
Published: (2019-06-01)

COMPARISON OF LIPID LOWERING EFFECTS OF ROSUVASTATIN AND ATORVASTATIN IN TYPE 2 DIABETIC PATIENTS WITH PRIMARY HYPERLIPIDEMIA
by: Safina Shabbir, et al.
Published: (2020-12-01)

The correlation of the efficacy and safety of statins with the aim of primary and secondary prevention: myths and reality
by: S R Gilyarevsky, et al.
Published: (2015-06-01)

Rosuvastatin Affects Tracheal Responsiveness, Bronchoalveolar Lavage Inflammatory Cells, and Oxidative Stress Markers in Hyperlipidemic and Asthmatic Rats
by: Saeideh Saadat, et al.
Published: (2019-10-01)

Statins in clinical practice
by: A. S. Sivkov, et al.
Published: (2010-04-01)

Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin
by: Masadeh Majed, et al.
Published: (2012-05-01)

A fixed-dose lisinopril and amlodipine combination in conjunction with rosuvastatin in patients with hypertensive disease and coronary heart disease
by: Z M Galeeva, et al.
Published: (2014-09-01)

Rosuvastatin and ellagic acid protect against isoproterenol-induced myocardial infarction in hyperlipidemic rats
by: Mai A. Elhemely, et al.
Published: (2014-12-01)

Statins in the treatment and the prevention of the progression of atherosclerosis of patients with coronary heart disease
by: T. E Morozova, et al.
Published: (2013-03-01)

Apolipoprotein E gene polymorphisms: a relationship with the risk of coronary artery disease and the effectiveness of lipid-lowering therapy with rosuvastatin
by: M. I. Churilin, et al.
Published: (2020-03-01)

Pleiotropic effects of statins
by: Narasaraju Kavalipati, et al.
Published: (2015-01-01)

Efficacy of a combination of cholesterol absorption and synthesis inhibitors in the correction of hyperlipidemia and dietary fat intolerance in patients with coronary heart disease (ESTHETICS trial)
by: M. G Bubnova, et al.
Published: (2013-03-01)

Oral use of "Low and Slow" Rosuvastatin with Co-Enzyme Q 10 in patients with Statin-Induced Myalgia: Retrospective case review
by: Madhurima Vidyarthi, et al.
Published: (2012-01-01)

COMPLEX ASSESSMENT OF EFFICACY OF STATINS PRESCRIBED AT MOST BY CLINICIANS
by: A. S. Sivkov, et al.
Published: (2018-06-01)

Short- and long-term effects on reproductive parameters of female Wistar rats after exposure to rosuvastatin starting in pre-puberty
by: Jorge W.F. Barros, et al.
Published: (2020-06-01)

PREDICTION OF THE INFLUENCE OF ORIGINAL AND GENERIC ROSUVASTATIN ON DIRECT MEDICAL COSTS OF SECONDARY PREVENTION IN PATIENTS WITH CHRONIC TYPES OF ISCHEMIC HEART DISEASE
by: E. I. Tarlovskaya, et al.
Published: (2015-08-01)

HYPOLIPIDEMIC AND PLEIOTROPIC EFFICACY OF ROSUVASTATIN IN ARTERIAL HYPERTENSION PATIENTS OF HIGH CARDIOVASCULAR RISK IN LONG-TERM OUTPATIENT FOLLOW-UP
by: V. P. Mikhin, et al.
Published: (2016-12-01)

Secondary prevention of coronary heart disease in clinical practice: choosing the treatment
by: M. G. Bubnova
Published: (2009-08-01)

Efficacy and safety of Mertenil (rosuvastatin) 40 mg in patients with familial hypercholesterolemia
by: M Yu Zubareva, et al.
Published: (2014-06-01)

Gut Microbiome Associates With Lipid-Lowering Effect of Rosuvastatin in Vivo
by: Yinhui Liu, et al.
Published: (2018-03-01)

Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly
by: Sydney B Long, et al.
Published: (2010-12-01)

Effects of statin on atherosclerosis of ascending aorta in patients undergoing coronary artery bypass grafting
by: Mehmet Ali Yesiltas, et al.
Published: (2021-04-01)

UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: N. F. Puchin'yan, et al.
Published: (2015-12-01)

The efficiency of dyslipidemia control in real clinical practice and the possibilities of its correction in patients with coronary heart disease and diabetes mellitus in the long -term use of simvastatin
by: F. Yu. Valikulova, et al.
Published: (2014-07-01)

The efficiency of dyslipidemia control in real clinical practice and the possibilities of its correction in patients with coronary heart disease and diabetes mellitus in the long -term use of simvastatin
by: F. Yu. Valikulova, et al.
Published: (2014-07-01)

New data on the use of rosuvastatin and acetylsalicyl acid for the prolongation of human life
by: M. V. Ezhov, et al.
Published: (2018-04-01)

Hypolidemic therapy today. New challenges and opportunities of statines
by: V. P. Mikhin, et al.
Published: (2018-04-01)

Dyslipidemia: A Trigger for Coronary Heart Disease in Romanian Patients with Diabetes
by: Mihnea-Alexandru Găman, et al.
Published: (2020-05-01)